$AMRN
AMARIN CORP PLC\UK

2021 Q2 Form 10-Q Financial Statement

#000095017021000845 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $154.5M $135.3M
YoY Change 14.17% 34.25%
Cost Of Revenue $32.16M $28.80M
YoY Change 11.66% 26.47%
Gross Profit $122.3M $106.5M
YoY Change 14.85% 36.53%
Gross Profit Margin 79.19% 78.72%
Selling, General & Admin $107.2M $92.40M
YoY Change 16.03% 25.87%
% of Gross Profit 87.63% 86.74%
Research & Development $6.357M $9.969M
YoY Change -36.23% 39.82%
% of Gross Profit 5.2% 9.36%
Depreciation & Amortization $785.0K $510.0K
YoY Change 53.92% 214.81%
% of Gross Profit 0.64% 0.48%
Operating Expenses $113.6M $102.4M
YoY Change 10.94% 27.1%
Operating Profit $8.773M $4.156M
YoY Change 111.09% -265.31%
Interest Expense $285.0K $151.0K
YoY Change 88.74% -80.86%
% of Operating Profit 3.25% 3.63%
Other Income/Expense, Net -$191.0K $108.0K
YoY Change -276.85% -213.68%
Pretax Income $8.867M $4.415M
YoY Change 100.84% -342.58%
Income Tax $1.059M $0.00
% Of Pretax Income 11.94% 0.0%
Net Earnings $7.808M $4.415M
YoY Change 76.85% -342.58%
Net Earnings / Revenue 5.05% 3.26%
Basic Earnings Per Share $0.02 $0.01
Diluted Earnings Per Share $0.02 $0.01
COMMON SHARES
Basic Shares Outstanding 395.9M 384.7M
Diluted Shares Outstanding 401.8M 399.7M

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $508.9M $550.3M
YoY Change -7.52% 148.13%
Cash & Equivalents $327.0M $214.0M
Short-Term Investments $181.9M $336.3M
Other Short-Term Assets $32.34M $27.50M
YoY Change 17.6% 219.57%
Inventory $272.5M $124.8M
Prepaid Expenses
Receivables $182.3M $125.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $996.0M $827.6M
YoY Change 20.35% 122.47%
LONG-TERM ASSETS
Property, Plant & Equipment $1.713M $10.61M
YoY Change -83.85% 1136.25%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $14.16M $61.04M
YoY Change -76.8%
Other Assets $456.0K $1.074M
YoY Change -57.54% -2.54%
Total Long-Term Assets $49.00M $87.27M
YoY Change -43.85% 386.94%
TOTAL ASSETS
Total Short-Term Assets $996.0M $827.6M
Total Long-Term Assets $49.00M $87.27M
Total Assets $1.045B $914.9M
YoY Change 14.22% 134.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $141.3M $86.76M
YoY Change 62.81% 155.03%
Accrued Expenses $226.5M $168.5M
YoY Change 34.41% 62.86%
Deferred Revenue $2.643M $5.706M
YoY Change -53.68% 190.83%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $22.46M
YoY Change -50.55%
Total Short-Term Liabilities $370.4M $283.5M
YoY Change 30.68% 53.32%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $5.528M $4.821M
YoY Change 14.67% -29.24%
Total Long-Term Liabilities $5.528M $4.821M
YoY Change 14.67% -83.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $370.4M $283.5M
Total Long-Term Liabilities $5.528M $4.821M
Total Liabilities $399.7M $312.1M
YoY Change 28.05% 29.59%
SHAREHOLDERS EQUITY
Retained Earnings -$1.423B -$1.427B
YoY Change -0.3% 0.89%
Common Stock $292.8M $285.7M
YoY Change 2.49% 14.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $59.01M $50.25M
YoY Change 17.43% 144.74%
Treasury Stock Shares $7.033M $5.742M
Shareholders Equity $645.3M $602.8M
YoY Change
Total Liabilities & Shareholders Equity $1.045B $914.9M
YoY Change 14.22% 134.63%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income $7.808M $4.415M
YoY Change 76.85% -342.58%
Depreciation, Depletion And Amortization $785.0K $510.0K
YoY Change 53.92% 214.81%
Cash From Operating Activities -$15.05M $1.587M
YoY Change -1048.52% -90.02%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $50.65M -$102.5M
YoY Change -149.43%
Cash From Investing Activities $50.65M -$102.5M
YoY Change -149.43% 12692.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 426.0K -14.15M
YoY Change -103.01% 219.86%
NET CHANGE
Cash From Operating Activities -15.05M 1.587M
Cash From Investing Activities 50.65M -102.5M
Cash From Financing Activities 426.0K -14.15M
Net Change In Cash 36.02M -115.0M
YoY Change -131.31% -1176.8%
FREE CASH FLOW
Cash From Operating Activities -$15.05M $1.587M
Capital Expenditures $0.00
Free Cash Flow $1.587M
YoY Change -90.5%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Shell Company
EntityShellCompany
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q2 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201912Member
dei Entity Registrant Name
EntityRegistrantName
AMARIN CORP PLC\UK
CY2021Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
amrn:AccruedLiabilitiesAndOtherLiabilitiesCurrent
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0000897448
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
dei Amendment Flag
AmendmentFlag
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-21392
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X0
dei Entity Address Address Line1
EntityAddressAddressLine1
77 Sir John Rogerson’s Quay
dei Entity Address Address Line2
EntityAddressAddressLine2
Block C
dei Entity Address Address Line3
EntityAddressAddressLine3
Grand Canal Docklands
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
2
dei Entity Address Country
EntityAddressCountry
IE
dei City Area Code
CityAreaCode
353 (0) 1
dei Local Phone Number
LocalPhoneNumber
6699 020
dei Security12b Title
Security12bTitle
American Depositary Shares (ADS(s)), each ADSrepresenting the right to receive one (1) Ordinary Share ofAmarin Corporation plc
dei Trading Symbol
TradingSymbol
AMRN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5724000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
432000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9153000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5528000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
327016000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186964000
CY2021Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3917000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
3915000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
181910000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
313969000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182259000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
154574000
CY2021Q2 us-gaap Inventory Net
InventoryNet
272455000
CY2020Q4 us-gaap Inventory Net
InventoryNet
188864000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28426000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30947000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
995983000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
879233000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1713000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2016000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
14158000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
62469000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7861000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8054000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
456000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24820000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13817000
CY2021Q2 us-gaap Assets
Assets
1044991000
CY2020Q4 us-gaap Assets
Assets
966021000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
141251000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
105876000
CY2021Q2 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
226545000
CY2020Q4 amrn Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
198641000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2643000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2926000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
370439000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
307443000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
14825000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15706000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8875000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6214000
CY2021Q2 us-gaap Liabilities
Liabilities
399667000
CY2020Q4 us-gaap Liabilities
Liabilities
338516000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
402255276
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
395222188
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
398425000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
392538081
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
292782000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
290115000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1834548000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1817649000
CY2021Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
7033088
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5886919
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
59011000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
51082000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1422995000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1429177000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
645324000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
627505000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1044991000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
966021000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
154488000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
135317000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
296658000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
290310000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32155000
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28797000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
60481000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
63604000
CY2021Q2 us-gaap Gross Profit
GrossProfit
122333000
CY2020Q2 us-gaap Gross Profit
GrossProfit
106520000
us-gaap Gross Profit
GrossProfit
236177000
us-gaap Gross Profit
GrossProfit
226706000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
107203000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
92395000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
213001000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
226332000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6357000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9969000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15734000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20247000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
113560000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
102364000
us-gaap Operating Expenses
OperatingExpenses
228735000
us-gaap Operating Expenses
OperatingExpenses
246579000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
8773000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4156000
us-gaap Operating Income Loss
OperatingIncomeLoss
7442000
us-gaap Operating Income Loss
OperatingIncomeLoss
-19873000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
285000
CY2020Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
151000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
756000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1359000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-672000
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1312000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-191000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
108000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-333000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8867000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4415000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7865000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18497000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1059000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1683000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2359000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7808000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
4415000
us-gaap Net Income Loss
NetIncomeLoss
6182000
us-gaap Net Income Loss
NetIncomeLoss
-16138000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
395899000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
384663000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
395272000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
373300000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
401767000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
399664000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
402778000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
373300000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
627505000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2059000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-7252000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13925000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1626000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
634611000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1028000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
75000
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-677000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2479000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
7808000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
645324000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
608263000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1306000
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-13831000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10591000
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-240000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
27925000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1164000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-633000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20553000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
585776000
CY2020Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
848000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
-238000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
51279000
us-gaap Increase Decrease In Accounts Payable And Other Operating Liabilities
IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
65530000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-773000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
1159000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33757000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
352000
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-521000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12131000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
4415000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
602763000
us-gaap Profit Loss
ProfitLoss
6182000
us-gaap Profit Loss
ProfitLoss
-16138000
amrn Depreciation And Amortization Excluding Amortization Of Intangible Assets
DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets
299000
amrn Depreciation And Amortization Excluding Amortization Of Intangible Assets
DepreciationAndAmortizationExcludingAmortizationOfIntangibleAssets
296000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1126000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-33000
us-gaap Share Based Compensation
ShareBasedCompensation
16404000
us-gaap Share Based Compensation
ShareBasedCompensation
22722000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
490000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
997000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
720000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27685000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8555000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
83591000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
48075000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2521000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10273000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
24000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
253084000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
131440000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
74510000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
527479000
amrn Disposal Purchase Of Furniture Fixtures And Equipment
DisposalPurchaseOfFurnitureFixturesAndEquipment
4000
amrn Disposal Purchase Of Furniture Fixtures And Equipment
DisposalPurchaseOfFurnitureFixturesAndEquipment
-251000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
178578000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-396290000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1028000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
848000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2134000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1658000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
238000
CY2020Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
6989000
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
401767000
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
399664000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
402778000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
373300000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-40009000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
140054000
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7929000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14352000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4767000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-430575000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
190879000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
648495000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
330933000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
217920000
us-gaap Interest Paid Net
InterestPaidNet
1193000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3711000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-20000
amrn Non Cash Or Part Non Cash Milestone Payment
NonCashOrPartNonCashMilestonePayment
12000000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q2 us-gaap Assets
Assets
1045000000.0
CY2021Q2 amrn Cash And Liquid Short Term And Long Term Investments
CashAndLiquidShortTermAndLongTermInvestments
523100000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
996000000.0
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
327000000.0
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
181900000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182300000
CY2021Q2 us-gaap Inventory Net
InventoryNet
272500000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
14200000
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
0
amrn Accounts Receivable Credit Period
AccountsReceivableCreditPeriod
P30D
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
373300000
CY2021Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
240747000
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
203875000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
182259000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
154574000
CY2021Q2 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
7808000
CY2020Q2 amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
4415000
amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
6182000
amrn Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-16138000
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
395899000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
384663000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
395272000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:12.25pt;text-indent:0.0pt;font-size:10.0pt;margin-top:13.5pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of Credit Risk</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:6.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents, short-term and long-term investments, and accounts receivable. The Company maintains substantially all of its cash and cash equivalents and short-term and long-term investments, in financial institutions believed to be of high-credit quality.</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A significant portion of the Company’s sales are to wholesalers in the pharmaceutical industry. The Company monitors the creditworthiness of customers to whom it grants credit terms and has not experienced any credit losses. The Company does not require collateral or any other security to support credit sales. </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Three</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> customers individually accounted for 10% or more of the Company’s gross product sales, Customers A, B, and C accounted for </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, of gross product sales for the six months ended June 30, 2021, and represented </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, of the gross accounts receivable balance as of June 30, 2021. Customers A, B, and C accounted for </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, of gross product sales for the six months ended June 30,</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;line-height:1.2458333333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2020 and represented </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and </span><span style="font-size:10.0pt;font-family:Times New Roman;color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, of the gross accounts receivable balance as of June 30, 2020</span><span style="color:rgba(0,0,0,1);font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company has not experienced any significant write-offs of its accounts receivable. All customer accounts are actively managed and no losses in excess of amounts reserved are currently expected; however, the Company is monitoring the potential negative impact of COVID-19 on the Company’s customers’ ability to meet their financial obligations.</span></p>
us-gaap Debt Instrument Term
DebtInstrumentTerm
P24M
CY2021Q2 amrn Held To Maturity Securities Continuous Unrealized Gain Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedGainLossPositionFairValue
100000
CY2020Q2 amrn Held To Maturity Securities Continuous Unrealized Gain Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedGainLossPositionFairValue
1300000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
66842000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
50657000
CY2021Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
48529000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
30388000
CY2021Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
157084000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
107819000
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2021-01-01
CY2021Q2 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P9Y9M18D
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32081000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20081000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7261000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
6264000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24820000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
13817000
amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
3872000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
206059000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
118601000
CY2021Q2 us-gaap Inventory Net
InventoryNet
272455000
CY2020Q4 us-gaap Inventory Net
InventoryNet
188864000
CY2021Q2 us-gaap Purchase Obligation
PurchaseObligation
213000000.0
CY2021Q2 amrn Communication Costs Pertaining To Marketing Commitments
CommunicationCostsPertainingToMarketingCommitments
7900000
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.05
CY2015Q1 amrn Equity Offering Costs
EquityOfferingCosts
700000
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.50
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19666637
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
810459
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
560755
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2100000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1700000
CY2021Q2 amrn Cash Discount Percent
CashDiscountPercent
0.02
CY2020Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
190827000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
409766000
amrn Provision Related To Prior Period Sales
ProvisionRelatedToPriorPeriodSales
854000
us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
212807000
amrn Credits Payments Made For Prior Period Sales
CreditsPaymentsMadeForPriorPeriodSales
168242000
CY2021Q2 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
218690000
CY2019Q4 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
128557000
us-gaap Valuation Allowances And Reserves Charged To Cost And Expense
ValuationAllowancesAndReservesChargedToCostAndExpense
361984000
CY2020Q2 amrn Valuation Allowances Provisions And Reserves Balance Net
ValuationAllowancesProvisionsAndReservesBalanceNet
162009000
us-gaap Revenue Practical Expedient Financing Component
RevenuePracticalExpedientFinancingComponent
true
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18632000
amrn Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
61000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1225000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17468000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20846000
amrn Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
3750000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4382000
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20214000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
1201000
amrn Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
ContractWithCustomerLiabilityRevenueRecognizedExcludingPerformanceObligationSatisfiedInPreviousPeriod
2845000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
22000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1097000
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.115
amrn Operating Lease Change In Weighted Average Discount Rate Percent
OperatingLeaseChangeInWeightedAverageDiscountRatePercent
0.01
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
10500000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10600000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7900000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8100000
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
500000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000.0
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
us-gaap Operating Lease Expense
OperatingLeaseExpense
800000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
771000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1774000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1808000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1842000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1876000
CY2021Q2 amrn Lessee Operating Lease Liability Payments Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter
9112000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17183000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6656000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1652000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8875000

Files In Submission

Name View Source Status
0000950170-21-000845-index-headers.html Edgar Link pending
0000950170-21-000845-index.html Edgar Link pending
0000950170-21-000845.txt Edgar Link pending
0000950170-21-000845-xbrl.zip Edgar Link pending
amrn-20210630.htm Edgar Link pending
amrn-20210630.xsd Edgar Link pending
amrn-20210630ex31_1.htm Edgar Link pending
amrn-20210630ex31_2.htm Edgar Link pending
amrn-20210630ex32_1.htm Edgar Link pending
amrn-20210630_cal.xml Edgar Link unprocessable
amrn-20210630_def.xml Edgar Link unprocessable
amrn-20210630_htm.xml Edgar Link completed
amrn-20210630_lab.xml Edgar Link unprocessable
amrn-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending